Publications

Highlighted Publications:

McLean K, Tan L, Bolland DE, Coffman LG, Peterson LF, Talpaz M, Neamati N, Buckanovich RJ:

Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth. Oncogene 38(9): 1576-1584, 2018. PM30305729

Hacker KE, Bolland DE, Tan L, Saha AK, Niknafs YS, Markovitz DM, McLean K: The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival. Neoplasia 20(12): 1209-1218, 2018. PM30412857/PMC6226625

Brackmann M, Stasenko M, Uppal S, Erba J, Reynolds RK, McLean K: Comparison of first-line

chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature. BMC Cancer 18(1): 172, 2017. PM29426293/PMC5810191

McLean K, Mehta G: Tumor Microenvironment and Models of Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium. Int J Gynecol Cancer 27(9S Suppl 5): S2-S9, 2017. PM29049091

Andersen CL, Sikora MJ, Boisen MM, Ma T, Christie A, Tseng G, Park YS, Luthra S, Chandran U,

Haluska P, Mantia-Smaldone G, Odunsi K, McLean K, Lee AV, Elishaev E, Edwards RP, Oesterreich S: Active estrogen receptor-alpha signaling in ovarian cancer models and clinical specimens. Clin Cancer Res 23(14): 3802-3812, 2017. PM28073843/PMC5503796

Stasenko M, Plegue M, Sciallis AP, McLean K: Clinical response to antiestrogen therapy in

platinum-resistant ovarian cancer patients and the role of tumor estrogen receptor expression status. International journal of gynecological cancer: official journal of the International Gynecological Cancer Society 25(2): 222-8, 2015. PM25500503

McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR,

Buckanovich RJ: Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 121(8): 3206-19, 2011. PM21737876/PMC3148732